| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 39.41B | 38.84B | 38.54B | 38.08B | 37.27B | 34.64B |
| Gross Profit | 8.09B | 8.68B | 7.29B | 6.27B | 9.04B | 7.83B |
| EBITDA | 6.35B | 6.85B | 5.92B | 4.58B | 6.99B | 5.67B |
| Net Income | 2.51B | 2.56B | 1.59B | 855.00M | 3.73B | 2.18B |
Balance Sheet | ||||||
| Total Assets | 76.21B | 77.14B | 78.68B | 74.97B | 72.80B | 70.92B |
| Cash, Cash Equivalents and Short-Term Investments | 7.63B | 7.93B | 8.74B | 7.84B | 9.01B | 10.00B |
| Total Debt | 15.07B | 16.71B | 16.55B | 16.79B | 17.45B | 17.09B |
| Total Liabilities | 29.21B | 30.74B | 33.63B | 32.73B | 30.93B | 31.84B |
| Stockholders Equity | 47.00B | 46.40B | 45.05B | 42.24B | 41.87B | 39.08B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.19B | 1.10B | -1.25B | -3.00B | 1.02B |
| Operating Cash Flow | 0.00 | 6.37B | 6.15B | 1.49B | 1.98B | 5.22B |
| Investing Cash Flow | 0.00 | -5.07B | -4.41B | -2.82B | -3.08B | -3.54B |
| Financing Cash Flow | 0.00 | -2.42B | -870.00M | 102.00M | 120.00M | -1.02B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥36.53B | 9.56 | ― | 1.90% | 2.15% | 16.14% | |
75 Outperform | ¥54.40B | 16.36 | ― | 2.92% | 3.03% | 28.27% | |
75 Outperform | ¥48.14B | 8.18 | ― | 5.04% | -3.21% | 27.18% | |
72 Outperform | ¥26.30B | 12.16 | ― | 3.84% | -3.41% | -12.83% | |
70 Outperform | ¥48.03B | 15.26 | ― | 3.77% | 8.54% | 6.93% | |
66 Neutral | ¥37.53B | 11.77 | ― | 2.37% | -11.70% | -54.82% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |